Kubota Pharmaceutical Holdings Co (TSE:4596) Other Operating Expense: 円20.94 Mil (TTM As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TSE:4596 Kubota Pharmaceutical Holdings Co Ltd TSE:4596
40 GF Score
Price 円65.00
GF Value 円33.61
Valuation Significantly Overvalued
! 2 Warning Signs
View Full Analysis

What is Kubota Pharmaceutical Holdings Co Other Operating Expense?

Kubota Pharmaceutical Holdings Co TSE:4596 +3.17% 40 Other Operating Expense is 円20.94 Mil as of Mar. 2026. GuruFocus rates TSE:4596 with a GF Score™ of 40/100 and a GF Value™ of 円33.61 (Significantly Overvalued). The stock has 2 warning signs investors should review.

Kubota Pharmaceutical Holdings Co's Other Operating Expense for the three months ended in Mar. 2026 was 円11.02 Mil. Its Other Operating Expense for the trailing twelve months (TTM) ended in Mar. 2026 was 円20.94 Mil.

Kubota Pharmaceutical Holdings Co's quarterly Other Operating Expense declined from Sep. 2025 (円4.07 Mil) to Dec. 2025 (円0.56 Mil) but then increased from Dec. 2025 (円0.56 Mil) to Mar. 2026 (円11.02 Mil).

Kubota Pharmaceutical Holdings Co's annual Other Operating Expense increased from Dec. 2023 (円110.50 Mil) to Dec. 2024 (円113.17 Mil) but then declined from Dec. 2024 (円113.17 Mil) to Dec. 2025 (円36.52 Mil).

Kubota Pharmaceutical Holdings Co Other Operating Expense Related Terms

Kubota Pharmaceutical Holdings Co Other Operating Expense Historical Data

* Premium members only.

The historical data trend for Kubota Pharmaceutical Holdings Co's Other Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Kubota Pharmaceutical Holdings Co Other Operating Expense Chart

Kubota Pharmaceutical Holdings Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Other Operating Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only -59.87 -73.71 110.50 113.17 36.52

Kubota Pharmaceutical Holdings Co Quarterly Data
Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Other Operating Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 26.60 5.29 4.07 0.56 11.02
TSE:4596
40GF Score
Kubota Pharmaceutical Holdings Co Ltd TSE:4596
Other Operating Expense is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Kubota Pharmaceutical Holdings Co Other Operating Expense Calculation

GuruFocus uses a standardized financial statement format for all companies. For non-financial companies, GuruFocus lists Selling, General, & Admin. Expense, , Research & Development, and Other Operating Expense under the "Total Operating Expense" section.

Other Operating Expense sometimes includes:
Restructuring, and merger
Acquisition related and other
Litigation settlement charge
Other (too numerous to list)

Some companies can and do choose to report each of these items separately. Yet, there are a variety of Other Operating Expense which are simply too numerous to list.

Other Operating Expense for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was 円20.94 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Other Operating Expense of 円20.94 Mil mean?
Kubota Pharmaceutical Holdings Co (TSE:4596) has a Other Operating Expense of 円20.94 Mil as of Mar. 2026. Other operating expenses that a company records on its income statement. View historical data on Kubota Pharmaceutical Holdings Co and its competitors.
Is Kubota Pharmaceutical Holdings Co's Other Operating Expense too high?
Kubota Pharmaceutical Holdings Co's current Other Operating Expense is 円20.94 Mil. Overall, Kubota Pharmaceutical Holdings Co has a GF Score™ of 40/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Kubota Pharmaceutical Holdings Co's Other Operating Expense compare to VRTX and REGN?
Kubota Pharmaceutical Holdings Co's Other Operating Expense of 円20.94 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Operating Expense for a Biotechnology company?
A good Other Operating Expense depends on the Biotechnology industry context. However, Other Operating Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Operating Expense mean?
A high Other Operating Expense can signal that a stock is expensive relative to its fundamentals. Other operating expenses that a company records on its income statement. View historical data on Kubota Pharmaceutical Holdings Co and its competitors. Kubota Pharmaceutical Holdings Co's current Other Operating Expense is 円20.94 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Kubota Pharmaceutical Holdings Co stock overvalued right now?
Based on GuruFocus' analysis, Kubota Pharmaceutical Holdings Co (TSE:4596) is currently considered Significantly Overvalued. The stock's GF Value™ is 円33.61, compared to a current price of 円65.00 — trading 93.4% above its estimated fair value. The current Other Operating Expense is 円20.94 Mil. Kubota Pharmaceutical Holdings Co's overall GF Score™ is 40/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Operating Expense calculated?
Other Operating Expense is calculated from a company's financial statements. For Kubota Pharmaceutical Holdings Co (TSE:4596), the current Other Operating Expense is 円20.94 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Kubota Pharmaceutical Holdings Co (TSE:4596) Overvalued in 2026?

Based on GuruFocus' analysis, Kubota Pharmaceutical Holdings Co stock appears to be overvalued. The current stock price of 円65.00 is trading 93.4% above its estimated GF Value™ of 円33.61. GuruFocus considers Kubota Pharmaceutical Holdings Co to be Significantly Overvalued.

Key valuation signals for TSE:4596:

  • Other Operating Expense: 円20.94 Mil
  • GF Value™: 円33.61 vs. price of 円65.00 (93.4% above fair value)
  • GF Score™: 40/100 with 2 warning signs

No single metric tells the full story. See the TSE:4596 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Kubota Pharmaceutical Holdings Co Business Description

Address 1-15-37 Minami-Aoyama, Minato-ku, Tokyo, JPN, 107-0062
Kubota Pharmaceutical Holdings Co Ltd is a Japanese company providing portfolio of drugs and devices to preserve and restore millions of people. It identifies and develops therapeutics to treat the opthalmic disorder and operations incidental or related thereto. Its pipeline products include VCM-Emixustat HCI, Lanosterol and Optogenetics.
40GF Score

Get the complete analysis for TSE:4596

Other Operating Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円65.00
Price
円33.61
GF Value